HQY vs WEX: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: WEX is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. HQY and WEX share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined HQY and WEX exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

HealthEquity, Inc. is the largest independent non-bank custodian of health savings accounts in the United States, and it also administers the flexible spending accounts, health reimbursement arrangements, COBRA and commuter benefits that sit alongside them. As of April 30, 2026 it held 10.6 million HSAs containing $37.1 billion of member assets, plus 7.2 million other consumer-directed benefit accounts, for 17.8 million total accounts. Almost none of that comes from consumers directly: it reaches members through their employers, and employers through benefits brokers, health plans and retirement recordkeepers. Revenue arrives in three lines: service fees from employers and members, custodial revenue on the interest spread from member cash placed with insurance-company partners and banks, and interchange on every swipe of a member's benefits card. Custodial is the biggest and by far the most profitable, at $174.3 million of the $354.6 million booked in the quarter ended April 30, 2026, against only $11.7 million of direct cost.

Full HQY guide

WEX Inc (NYSE: WEX) is a global commerce platform that provides embedded, largely closed-loop payment solutions across three segments. Mobility is a leading fleet-payments and fuel-card business that processes transactions and provides information management for fleets of all sizes; Benefits offers SaaS software plus payment tools for administering employee benefits such as HSAs and other consumer-directed accounts; and Corporate Payments delivers B2B virtual-card and accounts-payable automation for corporate and travel customers. The company earns money from transaction fees, interchange, account-servicing, interest on custodial deposits, and finance charges, which gives it a recurring, high-margin revenue base.

Full WEX guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• HQY drivers: The cash repricing ladder; Balances that compound whether or not accounts do.
• WEX drivers: Benefits and Corporate Payments growth; Margin expansion and capital return.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: Custodial revenue is the profit engine and it depends on rates HealthEquity does not control, so a sustained decline in market yields would eventually reset renewing contracts lower, just as slowly as the current tailwind arrived. For WEX, the single biggest swing factor is fuel: Mobility revenue rises and falls with fuel prices and gallons purchased, and a freight/trucking recession cut payment-processing transactions in 2025.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick HQY if you believe its drivers more; WEX if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the HQY and WEX guides.

HQY. HealthEquity runs a January fiscal year, so the quarter ended April 30, 2026 is fiscal 2027's first, reported May 28, 2026. Net debt is modest at roughly $680 million ($600 million of 4.50% notes due 2029 plus a drawn revolver, against $265 million of cash), which puts enterprise value near $9.3 billion, or about 15x the midpoint of guided adjusted EBITDA. Because custodial revenue carries almost no direct cost, small changes in the yield on member cash swing earnings far more than equivalent changes in account count.

WEX. WEX trades at a mid-teens trailing P/E and an even lower forward multiple, low for a payments platform, reflecting its fuel-price cyclicality and elevated leverage rather than a lack of profitability. The stock (around $150 in mid-2026) sits below some analyst fair-value estimates, which flag it as potentially undervalued but also as a possible value trap given the debt load. Adjusted EPS has been compounding in the high teens, faster than revenue, on efficiency and buybacks.

Headline figures (approximate, August 2026): HQY shows revenue (ttm) ~$1.34B, latest quarter (q1 fy2027, ended april 30, 2026) ~$354.6M revenue, +7% year over year, q1 fy2027 earnings ~$69.4M net income, ~$0.82 diluted (~$1.24 non-GAAP), hsa assets under custody ~$37.1B (~$17.5B cash, ~$19.6B invested); WEX shows revenue (ttm) ~$2.69B, q1 2026 revenue ~$674M (+5.8% YoY), q1 2026 adjusted eps ~$4.15 (+18% YoY), fy2026 revenue guidance ~$2.82B-$2.88B.

HQY and WEX are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined HQY and WEX exposure against your real portfolio. It is not an investment adviser.